Kangdong Liu Selected Research

Kangdong Liu Research Topics

Disease

88	Neoplasms (Cancer) 05/2022 - 06/2009
33	Esophageal Squamous Cell Carcinoma 01/2022 - 12/2012
21	Carcinogenesis 01/2022 - 06/2009
15	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 12/2012
10	Lung Neoplasms (Lung Cancer) 01/2021 - 05/2015
9	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 02/2015
8	Stomach Neoplasms (Stomach Cancer) 01/2022 - 06/2018
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 10/2014
6	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2016
6	Inflammation (Inflammations) 11/2021 - 09/2016
5	Infections 01/2022 - 02/2008
5	Skin Neoplasms (Skin Cancer) 01/2021 - 02/2012
5	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 07/2012
4	Melanoma (Melanoma, Malignant) 01/2021 - 05/2011
4	Colonic Neoplasms (Colon Cancer) 10/2020 - 06/2011
4	Carcinoma (Carcinomatosis) 11/2018 - 12/2014
4	Breast Neoplasms (Breast Cancer) 01/2017 - 06/2011
3	Mouth Neoplasms (Oral Cancer) 07/2021 - 04/2016
2	Esophagitis 01/2022 - 01/2017
2	Bone Resorption 01/2021 - 12/2016
2	Genomic Instability 01/2021 - 01/2021
2	COVID-19 01/2020 - 01/2020
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 07/2009
2	Triple Negative Breast Neoplasms 09/2019 - 06/2017
2	Neoplastic Cell Transformation 12/2018 - 01/2011
2	Squamous Cell Carcinoma of Head and Neck 05/2018 - 04/2016

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 02/2022 - 06/2009
13	Pharmaceutical PreparationsIBA 12/2021 - 06/2011
11	Phosphotransferases (Kinase)IBA 11/2021 - 11/2009
7	FlavonoidsIBA 01/2021 - 09/2013
7	Gefitinib (Iressa)FDA Link 01/2021 - 10/2014
6	CateninsIBA 01/2022 - 05/2017
5	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2015
5	AntioxidantsIBA 01/2021 - 04/2016
4	Aurora Kinase AIBA 01/2022 - 03/2019
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2012
4	EnzymesIBA 01/2021 - 07/2015
4	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021 - 11/2011
4	aloe emodinIBA 12/2018 - 07/2012
3	MicroRNAs (MicroRNA)IBA 01/2022 - 04/2019
3	CarcinogensIBA 01/2022 - 11/2009
3	CytokinesIBA 01/2022 - 01/2020
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2020
3	AntigensIBA 08/2021 - 06/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2021 - 05/2018
3	Therapeutic UsesIBA 04/2021 - 05/2016
3	Protein Kinases (Protein Kinase)IBA 01/2021 - 06/2011
3	p21-Activated KinasesIBA 01/2021 - 01/2020
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021 - 09/2013
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2018
3	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2020 - 07/2015
3	Small Interfering RNA (siRNA)IBA 02/2018 - 06/2009
2	Biological ProductsIBA 02/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2019
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022 - 05/2018
2	Eflornithine (Ornidyl)FDA Link 01/2022 - 01/2017
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 01/2021
2	ubenimexIBA 11/2021 - 06/2019
2	IntegrinsIBA 10/2021 - 10/2011
2	IsoflavonesIBA 01/2021 - 05/2017
2	Monoclonal AntibodiesIBA 01/2021 - 01/2020
2	Caspase 3 (Caspase-3)IBA 10/2020 - 12/2019
2	Annexin A5IBA 01/2020 - 01/2020
2	xanthohumolIBA 01/2020 - 01/2019
2	CaspasesIBA 01/2020 - 05/2018
2	Antimalarials (Antimalarial Agents)IBA 01/2020 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 07/2016
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020 - 09/2016
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2020 - 11/2018
2	ProteomeIBA 11/2019 - 01/2019
2	NF-kappa B (NF-kB)IBA 09/2019 - 01/2019
2	polypeptide 3 90kDa ribosomal protein S6 kinaseIBA 09/2019 - 01/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2018 - 06/2011
2	VaccinesIBA 11/2018 - 10/2016
2	eupatilinIBA 06/2018 - 09/2016
2	oridoninIBA 05/2018 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 02/2018 - 12/2015
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2018 - 05/2011
2	Estrogen ReceptorsIBA 06/2017 - 01/2017
2	theasinensin AIBA 06/2017 - 12/2012
2	Histone Deacetylase InhibitorsIBA 06/2017 - 06/2015
2	trichostatin A (A 300)IBA 06/2017 - 12/2012
2	ProstaglandinsIBA 01/2017 - 02/2015
2	PolyaminesIBA 01/2017 - 07/2015
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2015 - 07/2012
2	TensinsIBA 09/2015 - 07/2012
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2015 - 07/2012
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2015 - 02/2015
2	chrysinIBA 01/2014 - 09/2013
1	ginsenoside Rh2IBA 05/2022
1	HippocalcinIBA 02/2022
1	CalciumIBA 02/2022
1	AnthracyclinesIBA 01/2022
1	Anesthetics (Anesthetic Agents)IBA 01/2022

Therapy/Procedure

16	Therapeutics 12/2021 - 06/2009
10	Chemoprevention 01/2022 - 02/2012
6	Drug Therapy (Chemotherapy) 01/2022 - 01/2014
3	Oral Administration 11/2021 - 09/2018
2	Aftercare (After-Treatment) 01/2022 - 01/2020
2	Immunotherapy 01/2021 - 01/2019